Link Therapeutics
Latest round
- Series B
Last raised
- Jul 2025
Total raised
- $7.8M
Investors
- 5
About Link Therapeutics
Founded in 2022 and based in Kyoto, Japan, Link Therapeutics is a biotechnology company that develops treatments that target autoantibodies. Link Therapeutics operates as a biotechnology company that engages in the research and development of treatments that target autoantibodies. In July 2025, Link Therapeutics Inc.
Who invested in Link Therapeutics
5 investors across 2 rounds
See all investors in Link Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Link Therapeutics
Who invested in Link Therapeutics?
Link Therapeutics has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Link Therapeutics raised?
Link Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Link Therapeutics last raise money?
Link Therapeutics's most recent round on record is a Series B, in Jul 2025.
What does Link Therapeutics do?
Founded in 2022 and based in Kyoto, Japan, Link Therapeutics is a biotechnology company that develops treatments that target autoantibodies.
Where is Link Therapeutics headquartered?
Link Therapeutics is headquartered in Kyoto-shi, Japan.
Which VCs invest in companies like Link Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Link Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Link Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.